Antiemetic Management with Metoclopramide ± Omeprazole in Patients Receiving Multiple Antibiotics

1. Indications and Rationale

Antibiotic regimens, especially multi‑drug tuberculosis therapy, are recognized causes of medication‑induced nausea and vomiting; symptomatic anti‑emetic treatment is therefore indicated. 1

The National Comprehensive Cancer Network (NCCN) recommends metoclopramide as a dopamine‑antagonist for medication‑induced nausea, with oral dosing of 20–30 mg taken 3–4 times daily. 4
For initial therapy, a lower dose of 10–20 mg orally three times daily as needed is supported; if symptoms persist, a scheduled (around‑the‑clock) regimen may be used for up to one week before reassessment. 1
Metoclopramide should be limited to a maximum of 12 weeks of use because the risk of tardive dyskinesia (TD) rises with longer treatment duration. 7
Higher cumulative doses of metoclopramide further increase the likelihood of TD. 6

Adding omeprazole 20–40 mg daily for gastric acid suppression is recommended to mitigate potential gastric irritation from the antibiotic regimen and to provide additional symptomatic relief. 7

If nausea remains uncontrolled after one week of metoclopramide ± omeprazole, the NCCN advises adding a serotonin (5‑HT₃) antagonist (e.g., ondansetron or granisetron). 4
Combining anti‑emetics with different mechanisms (dopamine antagonism plus 5‑HT₃ blockade) yields synergistic anti‑emetic effects. 5

When metoclopramide is not tolerated, alternative agents such as prochlorperazine, promethazine, or antihistamines may be employed. 1

Re‑evaluate the underlying cause of nausea if symptoms persist beyond one week of therapy. 4
For acute dystonic reactions to metoclopramide, diphenhydramine is recommended; benztropine may be used if diphenhydramine allergy exists. 4

Evidence level for the above statements is not explicitly graded in the cited sources.